Laxminarayan Bhat
Net worth: 50 803 $ as of 31/05/2026
Net worth: 50 803 $ as of 31/05/2026
Dr. Laxminarayan Bhat is a President, Chief Executive Officer & Director at Reviva Pharmaceuticals Holdings, Inc. and a President, Chief Executive Officer & Director at Reviva Pharmaceuticals, Inc. He is on the Board of Directors at Reviva Pharmaceuticals Holdings, Inc. and Reviva Pharmaceuticals, Inc. Dr. Bhat was previously employed as a Research Scientist by ARYx Therapeutics, Inc. and a Research Scientist by XenoPort, Inc. He received his doctorate degree from North-Eastern Hill University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/03/2026 | 124,213 ( 0.97% ) | 50 803 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Founder | 11/12/2020 |
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Founder | 01/01/2006 |
| Companies | Position | End |
|---|---|---|
| ARYX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/01/2006 |
| XENOPORT, INC. | Chief Tech/Sci/R&D Officer | 02/01/2004 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Health Technology |
ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
North-Eastern Hill University
North-Eastern Hill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system, cardio vascular, metabolic and inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions